scholarly journals Long-term outcomes in patients undergoing resection, ablation, and trans-arterial chemoembolization of hepatocellular carcinoma in the United States: a national cancer database analysis

2019 ◽  
Vol 1 (1) ◽  
pp. 55-60
Author(s):  
Yoshikuni Kawaguchi ◽  
Yi-Ju Chiang ◽  
Jenilette D. Velasco ◽  
Ching-Wei D Tzeng ◽  
Jean-Nicolas Vauthey
Keyword(s):  
United States ◽  
Hepatocellular Carcinoma ◽  
The United States ◽  
National Cancer Database ◽  
Long Term Outcomes ◽  
Database Analysis ◽  
Arterial Chemoembolization

Su1285 Long-Term Survival of Patients With Transplant-Eligible Hepatocellular Carcinoma (HCC) in Post-MELD Exception Era in the United States Between 2004 and 2007

2013 ◽  
Vol 144 (5) ◽  
pp. S-447-S-448
Author(s):  
Pardha Devaki ◽  
Vidyasagargoud Marupakula ◽  
Sharad Nangia ◽  
Basile Njei ◽  
Ivo C. Ditah ◽  
...  
Keyword(s):  
United States ◽  
Hepatocellular Carcinoma ◽  
The United States ◽  
Term Survival ◽  
Long Term Survival

Can Therapy of Hepatitis C Affect the Development of Hepatocellular Carcinoma?

2006 ◽  
Vol 4 (8) ◽  
pp. 751-757 ◽  
Author(s):  
Laura M. Kulik
Keyword(s):  
United States ◽  
Hepatocellular Carcinoma ◽  
Hepatitis C ◽  
Hepatitis B ◽  
Viral Infections ◽  
The United States ◽  
Primary Treatment ◽  
Term Survival ◽  
The Past

Chronic inflammation induced by viral infections and their role in carcinogenesis is well recognized. Two hepatotropic viruses, hepatitis B and hepatitis C (HCV), have been linked worldwide to the development of hepatocellular carcinoma (HCC). Although orthotopic liver transplant offers the best chance for cure and long-term survival, the demand for organs far outweighs the supply. The incidence of HCC in the United States has increased over the past 3 decades. HCV-induced cirrhosis is believed to play a significant role in the rising rate of HCC. Therefore, primary measures to prevent HCC in HCV-infected patients are urgently needed. Numerous studies of the HCV HCC patient have considered primary treatment with interferon-based therapy. However, secondary prevention currently seems to carry more promise. This article evaluates and assesses various treatments for primary and secondary chemoprevention in the setting of HCV.

scholarly journals National Trends and Long-term Outcomes of Liver Transplant for Alcohol-Associated Liver Disease in the United States

2019 ◽  
Vol 179 (3) ◽  
pp. 340 ◽  
Author(s):  
Brian P. Lee ◽  
Eric Vittinghoff ◽  
Jennifer L. Dodge ◽  
Giuseppe Cullaro ◽  
Norah A. Terrault
Keyword(s):  
United States ◽  
Liver Disease ◽  
Liver Transplant ◽  
The United States ◽  
Long Term Outcomes ◽  
National Trends
Sign in / Sign up

Export Citation Format

Share Document